Azura Ophthalmics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$22M
- Investors
-
6
Azura Ophthalmics General Information
Description
Developer of ophthalmic keratolytic intended for the treatment of disorders affecting the lid margin and ocular surface. The company is developing an innovative portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for Meibomian Gland Dysfunction (MGD), enabling healthcare professionals to approach the treatment of ocular surface disease.
Contact Information
Website
www.azuraophthalmics.comCorporate Office
- 5 Druyanov Street
- Tel Aviv 6314305
- Israel
Corporate Office
- 5 Druyanov Street
- Tel Aviv 6314305
- Israel
Azura Ophthalmics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 11-Feb-2022 | $22M | Completed | Clinical Trials - Phase 3 | ||
| 4. Later Stage VC (Series C) | 22-Oct-2020 | Completed | Clinical Trials - Phase 3 | |||
| 3. Later Stage VC (Series C) | 19-Jan-2020 | Cancelled | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series B) | 10-Oct-2017 | $16M | $17.2M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 11-Mar-2014 | $1.2M | $1.2M | Completed | Startup |
Azura Ophthalmics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B | ||||||||
| Preferred A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Azura Ophthalmics Comparisons
Industry
Financing
Details
Azura Ophthalmics Competitors (1)
One of Azura Ophthalmics’s competitors is Novaliq, a Venture Capital-Backed company based in Heidelberg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novaliq | Venture Capital-Backed | Heidelberg, Germany |
Azura Ophthalmics Patents
Azura Ophthalmics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260174877-A1 | Compounds and methods for the treatment of dermal and ocular disorders | Pending | 19-Dec-2024 | ||
| US-20260053711-A1 | Semi-solid pharmaceutical composition micro-dispenser | Pending | 20-Aug-2024 | ||
| WO-2026041906-A1 | Semi-solid pharmaceutical composition micro-dispenser | Pending | 20-Aug-2024 | ||
| EP-4739291-A2 | Administration of keratolytics to ocular and periocular surfaces | Pending | 07-Jul-2023 | ||
| WO-2025012701-A2 | Administration of keratolytics to ocular and periocular surfaces | Inactive | 07-Jul-2023 | A61K9/0048 |
Azura Ophthalmics Signals
Azura Ophthalmics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brandon Biocatalyst | Venture Capital | Minority | ||
| Brandon Capital | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| TPG | PE/Buyout | Minority | ||
| Elron Ventures | Venture Capital | Minority |
Azura Ophthalmics FAQs
-
When was Azura Ophthalmics founded?
Azura Ophthalmics was founded in 2013.
-
Where is Azura Ophthalmics headquartered?
Azura Ophthalmics is headquartered in Tel Aviv, Israel.
-
What is the size of Azura Ophthalmics?
Azura Ophthalmics has 11 total employees.
-
What industry is Azura Ophthalmics in?
Azura Ophthalmics’s primary industry is Drug Discovery.
-
Is Azura Ophthalmics a private or public company?
Azura Ophthalmics is a Private company.
-
What is Azura Ophthalmics’s current revenue?
The current revenue for Azura Ophthalmics is .
-
How much funding has Azura Ophthalmics raised over time?
Azura Ophthalmics has raised $59.2M.
-
Who are Azura Ophthalmics’s investors?
Brandon Biocatalyst, Brandon Capital, OrbiMed, TPG, and Elron Ventures are 5 of 6 investors who have invested in Azura Ophthalmics.
-
Who are Azura Ophthalmics’s competitors?
Novaliq is a competitor of Azura Ophthalmics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process